微创结直肠手术后硬膜外镇痛与常规静脉镇痛的随机临床试验
该随机对照试验纳入87例微创结直肠手术患者,比较胸段硬膜外镇痛(EA)与常规静脉镇痛(IA)的效果。结果显示两组在住院时间、每日视觉模拟评分、镇痛总体获益评分及开始经口进食时间上相当,但EA组低血压收缩压(<90 mmHg)发作发生率更高(9 vs 2;p<0.05),且EA组阿片类药物总用量有更高趋势。结论认为EA在微创结直肠手术中无额外临床获益。
要点
- EA与IA在住院时间、疼痛评分及镇痛获益评分上等效。
- EA组低血压收缩压(<90 mmHg)发作次数显著高于IA组(9 vs 2)。
- EA组阿片类药物总用量有增高趋势,但差异未达统计学显著。
核心结论
- 微创结直肠手术后硬膜外镇痛相比常规静脉镇痛无额外临床获益。
- 硬膜外镇痛与更高的低血压收缩压(<90 mmHg)发作发生率相关。
- 硬膜外镇痛有阿片类药物总用量更高及并发症增多的趋势。
研究设计与样本
- 随机对照试验,单中心,2011至2014年纳入87例微创结直肠手术患者。
- 排除8例后,38例随机分配至硬膜外镇痛组,41例至静脉镇痛组。
- 每日采用视觉模拟评分评估疼痛,采用镇痛总体获益评分评估生活质量至出院。
主要发现
- 两组平均年龄57±14岁,女性占43%,平均BMI 28.6±6 kg/m2,人口学特征及诊断和手术分布相似。
- 硬膜外镇痛组低血压收缩压(<90 mmHg)发作次数为9次,静脉镇痛组为2次(p<0.05)。
- 两组平均住院时间均为4±3天,每日视觉模拟评分分别为2.4±2.0与3.0±2.0,镇痛总体获益评分均为3.2±2.0。
- 硬膜外镇痛组阿片类药物总用量为147.5±192.0 mg,静脉镇痛组为98.1±112.0 mg(p>0.05)。
- 两组总住院费用分别为$144,991±$67,636与$141,339±$75,579(p>0.05)。
临床怎么用
- 微创结直肠手术后可不将胸段硬膜外镇痛作为常规首选镇痛方式。
- 选择硬膜外镇痛时需警惕低血压收缩压(<90 mmHg)发作风险。
- 硬膜外镇痛可能增加阿片类药物总用量,需加强监测。
局限性
- 单中心研究,样本量有限(硬膜外镇痛组38例,静脉镇痛组41例)。
- 部分结果如阿片类药物用量差异未达统计学显著,仅为趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effectiveness of thoracic epidural analgesia (EA) vs conventional IV analgesia (IA) after minimally invasive surgery is still unproven. We designed a randomized controlled trial comparing EA with IA after minimally invasive colorectal surgery. STUDY DESIGN: A total of 87 patients who underwent minimally invasive colorectal procedures at a single institution between 2011 and 2014 were enrolled. Eight patients were excluded and 38 were randomized to EA and 41 to IA. Pain was assessed with the Visual Analogue Scale and quality of life with the Overall Benefit of Analgesia Score daily until discharge. RESULTS: Mean age was 57 ± 14 years, 43% of patients were female, and mean BMI was 28.6 ± 6 kg/m2. The 2 groups were similar in demographic characteristics and distribution of diagnoses and procedures. Epidural analgesia had a higher incidence of hypotensive systolic blood pressure (<90 mmHg) episodes (9 vs 2; p < 0.05) and a trend toward longer Foley catheter duration (3 ± 2 days vs 2 ± 4 days; p > 0.05). Epidural and IA had equivalent mean lengths of stay (4 ± 3 days vs 4 ± 3 days), daily Visual Analogue Scale scores (2.4 ± 2.0 vs 3.0 ± 2.0), and Overall Benefit of Analgesia Scores (3.2 ± 2.0 vs 3.2 ± 2.0), and similar time to start oral diet (2.8 ± 2 days vs 2.2 ± 1 days). Epidural analgesia patients used a higher total dose of narcotics (147.5 ± 192.0 mg vs 98.1 ± 112.0 mg; p > 0.05). Epidural and IV analgesia had equivalent total hospital charges ($144,991 ± $67,636 vs $141,339 ± $75,579; p > 0.05). CONCLUSIONS: This study indicates that EA has no added clinical benefit in patients undergoing minimally invasive colorectal surgery. A trend toward higher total narcotics use and complications with EA was demonstrated.
引用
- Hanna MH, Jafari MD, Jafari F, et al. Randomized Clinical Trial of Epidural Compared with Conventional Analgesia after Minimally Invasive Colorectal Surgery. J Am Coll Surg. 2017. PMID: 28782603. doi:10.1016/j.jamcollsurg.2017.07.1063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。